Topics

Food and Drug Administration
Experimental Ebola drug ZMapp begins clinical trials in Liberia
Experimental Ebola drug ZMapp begins clinical trials in Liberia

ZMapp, the experimental Ebola drug that won notoriety when it was given to a handful of infected aid workers at the height of the epidemic, will now begin clinical testing in Liberian treatment centers, U.S. health authorities said. "Although ZMapp has been used to treat several Ebola-infected patients in recent months, we cannot determine if the drug actually benefited those patients because it was not administered within the context of a clinical trial," said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. "This clinical trial will help us determine if ZMapp and other treatments are safe and effective for use in the...

Loading